New clinical data further supports accuracy of the Vysis UroVysion test.
D004345:Drug Industry; D004348:Drug Labeling; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008137:Longitudinal Studies; D025202:Molecular Diagnostic Techniques / Q000592:standards*; D015337:Multicenter Studies as Topic; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000235:genetics; D012680:Sensitivity and Specificity; D014481:United States; D014486:United States Food and Drug Administration; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000235:genetics